C-type natriuretic peptide (CNP) has therapeutic potential in heart failure with preserved ejection fraction (HFpEF) due to its broad range of beneficial effects on cardiovascular structure and functi
Note: Continuous variable values were expressed as Mean±SD. Categorical variables were expressed as n(%). BMI, body mass index; LVEF, left ventricular ejection fraction; PMI, postoperative myocardial
SD—standard deviation; CABG—cardiac artery bypass graft, NYHA—New York Heart Association. Baseline characteristics of the entire group, separated into rheumatic and non-rheumatic patients.
Heart failure with preserved ejection fraction accounts for a large proportion of heart failure, and it is closely related to a high hospitalization rate and high mortality rate of cardiovascular dise
